Animal Pain Management Market Growth, Market Insights and Forecast to 2025

Posted by rekha on October 28th, 2019

 The global animal pain management market is expected to reach US$ 1,679.8 Mn by 2025. Pain is a sensitivity that the brain creates from input called “nociception”. The stimulus can be generated from temperature, physical, inflammatory or chemical injuries to tissues. The aspects which are driving the growth of global animal pain management market are swelling occurrence of osteoarthritis, cancer and other pain disorders, upsurge in veterinary specialists and promising government strategies to improve the awareness among the people. For instance, International Veterinary Academy of Pain Management (IVPM) creates awareness among the veterinary professionals concerning about animal pain prevention, management. They also educate pet owners about health and welfare in acute or chronic pain management. Enlarged pet lovers together with better veterinary pain management centers are anticipated to create demand for global animal pain management market in the forecast period. On the flip side, growing pet care costs, rigorous regulatory approval process for pain management drugs, and lack of animal healthcare awareness in emerging markets are impeding the growth of global animal pain management market.

Global animal pain management market is segmented on the basis of product type, application, animal type, end user, and region.

Request for Sample Report @

OsteoarthritisDominate the Global Animal Pain Management Market

Based on the application, global animal pain management market is segmented into osteoarthritis, cancer-related pain, spinal pain, others. Osteoarthritis dominated the global animal pain management market due to the growing frequency of joint pain due to osteoarthritis among the older animals. Besides, increasing occurrence of musculoskeletal disorders and growing population of obese and overweight pets are also streaming the growth of global animal pain management market.


North America Leads the Global Animal Pain Management Market

PBI’s global animal pain management market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global animal pain management market through 2014-2018 and expected to dominate over 2019-2025 owing to the massive pet population in the region, growing animal healthcare outlay, huge number of hospitals & clinics, mounting pool of veterinarians, and high frequency of diseases causing pain. Additionally, rising number of research and funding events in the field of veterinary pain management is also aiding the growth of animal pain management market in the region. Europe animal pain management market is showing a significant growth owing to increased consciousness among the pet lovers. Germany’s animal pain management market is expected to dominate the regional revenue share. Besides, rising per capita income, swelling adoption of small animals such as cats and dogs are anticipated to boost the growth of animal pain management market in the region. The Asia Pacific veterinary pain management market is valued to grow at the highest CAGR over the coming years. Moreover, countries such as Japan, China, and India are projected to provide momentous growth breaks for market players. These countries have a large livestock population, as well a rising trend of pet ownership.

Launch of newer products, and strategic alliances are the key strategies adopted by market players


Global animal pain management market further reveals that the key player’s increasingly adopting strategies such as launch of newer products, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

  • For instance, In January 2017, Elanco launched gallant (Grapriprant tablets) for treatment of management of pain and inflammation associated with canine osteoarthritis.
  • Zoetis acquires Nexvet Biopharma for around million. The acquisition gave Zoetis ownership of ranevetmab, a mAb targeting nerve-growth factor (NGF) for treatment of chronic pain associated with osteoarthritis in dogs.

Key player’s profiles in the report are Zoetis Inc., Elanco, Merial, Bayer Animal Health, Virbac S.A., IDEXX Laboratories, Boehringer Ingelheim Vetmedica, Ceva Sante Animale, Vetoquinol S.A.

Precision Business Insights (PBI) in its report titled “Global Animal Pain Management Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Detailed Segmentation


By Product Type

  • Non-opioids
  • Opioids


By Application

  • Osteoarthritis
  • Cancer-related pain
  • Spinal pain
  • Others


By Animal Type

  • Small Pets

o   Canine

o   Feline

  • Swine
  • Bovine
  • Horses
  • Others


By End User

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others




o     North America

  • US
  • Canada

o     Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information:

Like it? Share it!


About the Author

Joined: July 26th, 2019
Articles Posted: 219

More by this author